Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Net Income - Minority (2016 - 2025)

Cumberland Pharmaceuticals' Net Income - Minority history spans 14 years, with the latest figure at $336100.0 for Q4 2025.

  • For Q4 2025, Net Income - Minority rose 9.29% year-over-year to $336100.0; the TTM value through Dec 2025 reached $336100.0, up 9.29%, while the annual FY2025 figure was $336100.0, 9.29% up from the prior year.
  • Net Income - Minority for Q4 2025 was $336100.0 at Cumberland Pharmaceuticals, up from $307517.0 in the prior quarter.
  • Across five years, Net Income - Minority topped out at $336100.0 in Q4 2025 and bottomed at $139283.0 in Q1 2021.
  • The 3-year median for Net Income - Minority is $225934.5 (2021), against an average of $231813.0.
  • The largest annual shift saw Net Income - Minority soared 195.44% in 2021 before it rose 9.29% in 2025.
  • A 3-year view of Net Income - Minority shows it stood at $144352.0 in 2021, then surged by 113.03% to $307517.0 in 2024, then rose by 9.29% to $336100.0 in 2025.
  • Per Business Quant, the three most recent readings for CPIX's Net Income - Minority are $336100.0 (Q4 2025), $307517.0 (Q4 2024), and $144352.0 (Q2 2021).